ArticleTurkish journal of biology = Turk biyoloji dergisi2025
FDA-approved drugs as potential covalent inhibitors of key SARS-CoV-2 proteins: an in silico approach.
Murat Serilmez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.